Trials / Withdrawn
WithdrawnNCT02885987
Use of Accessory Device AmplifEYE During Average Risk Screening Colonoscopy to Increase Adenoma Detection Rate
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- Loma Linda University · Academic / Other
- Sex
- All
- Age
- 50 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this investigator-initiated study is to determine whether the use of an accessory device called AmplifEYE can improve colonoscopy quality in patients who are undergoing average risk colorectal cancer screening. Primary end point is adenoma detection rates.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | AmplifEYE | AmplifEYE will be attached to the tip of the colonoscope prior to start of procedure. |
Timeline
- Start date
- 2017-08-03
- Primary completion
- 2022-03-01
- Completion
- 2022-03-01
- First posted
- 2016-09-01
- Last updated
- 2020-10-20
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT02885987. Inclusion in this directory is not an endorsement.